Home > Back to Publisher > Report Information

OTC Healthcare in the UK to 2011

Datamonitor
August 11, 2008
190 Pages - SKU: DFMN1872796

Abstract Table of Contents Search inside this report Related Reports

Countries covered: United Kingdom

Introduction

This databook is a detailed information resource covering all the key data points on OTC Healthcare in the UK. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2006 and full forecasts to 2011.

Scope

Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products
Provides market value, volume, expenditure and consumption data by market, segment and subsegment
Includes company and brand share data by categories

Highlights

The market for OTC Healthcare in the UK increased between 2001-2006, growing at an average annual rate of 2.8%.

The leading company in the market in 2006 was GlaxoSmithKline Plc. The second-largest player was Pfizer Inc with Reckitt Benckiser PLC in third place.

Reasons to Purchase

Discover the major quantitative trends affecting the OTC Healthcare markets
Understand consumers' consumption and expenditure patterns
Understand the future direction of the market with reliable historical data and full five year forecasting

Additional Information

Databooks are a detailed information resource covering all the key data points across all industry verticals. They provide data covering a particular market at country or regional level in comprehensive tabular and brief contextual format. The databook allows the user to study and analyze the data. This databook is comprised of an overview chapter covering the market as a whole, a chapter examining each category within the market, and a chapter containing socioeconomic analysis and data. It also includes a chapter detailing Datamonitor’s research methodology, and an appendix containing additional details.

Chapter 1 EXECUTIVE SUMMARY
: Summary Market Level - OTC Healthcare; Summary category level - Analgesics; Summary category level - Cough and Cold Preparations; Summary category level - Traditional Medicines; Summary category level - First Aid Kits; Summary category level - Indigestion Preparations; Summary category level - Vitamins and Minerals; Summary category level - Plasters & Bandages; Summary category level - Medicated Skin Products; Summary category level - Other OTC Healthcare Products; Summary category level - Topical OTC Medicines
Chapter 2 INTRODUCTION
: What is this report about?; How to use this report; Market Definition
Chapter 3 MARKET OVERVIEW
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 4 LEADING COMPANY PROFILES
: GlaxoSmithKline Plc; Pfizer Inc
Chapter 5 CATEGORY ANALYSIS - ANALGESICS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 6 CATEGORY ANALYSIS - COUGH AND COLD PREPARATIONS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 7 CATEGORY ANALYSIS - TRADITIONAL MEDICINES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 8 CATEGORY ANALYSIS - FIRST AID KITS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 9 CATEGORY ANALYSIS - INDIGESTION PREPARATIONS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 10 CATEGORY ANALYSIS - VITAMINS AND MINERALS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 11 CATEGORY ANALYSIS - PLASTERS & BANDAGES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 12 CATEGORY ANALYSIS - MEDICATED SKIN PRODUCTS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 13 CATEGORY ANALYSIS - OTHER OTC HEALTHCARE PRODUCTS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 14 CATEGORY ANALYSIS - TOPICAL OTC MEDICINES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 15 COUNTRY COMPARISON
: Value; Market Share
Chapter 16 NEW PRODUCT DEVELOPMENT
: Product launches over time; Recent product launches
Chapter 17 UK SOCIOECONOMIC PROFILE
: Country Overview; Key Facts; Political Overview; UK Economic Overview
Chapter 18 UK MACROECONOMIC PROFILE
: Macroeconomic Indicators
Chapter 19 RESEARCH METHODOLOGY
: Methodology overview; Secondary research; Market modelling; Primary research; Data finalisation; Ongoing research
Chapter 20 APPENDIX
: Future readings; How to contact experts in your industry
LIST OF FIGURES
: Figure 1: UK OTC Healthcare value & value forecast, 2001-2011 (GBP m, nominal prices); Figure 2: UK OTC Healthcare category growth comparison, by value, 2001-2011; Figure 3: UK OTC Healthcare company share, by value, 2005-2006 (%); Figure 4: UK Analgesics value & value forecast, 2001-2011 (GBP m, nominal prices); Figure 5: UK Analgesics category growth comparison, by value, 2001-2011; Figure 6: UK Analgesics company share, by value, 2005-2006 (%); Figure 7: UK Cough and Cold Preparations value & value forecast, 2001-2011 (GBP m, nominal prices); Figure 8: UK Cough and Cold Preparations category growth comparison, by value, 2001-2011; Figure 9: UK Cough and Cold Preparations company share, by value, 2005-2006 (%); Figure 10: UK Traditional Medicines value & value forecast, 2001-2011 (GBP m, nominal prices); Figure 11: UK Traditional Medicines company share, by value, 2005-2006 (%); Figure 12: UK First Aid Kits value & value forecast, 2001-2011 (GBP m, nominal prices); Figure 13: UK First Aid Kits company share, by value, 2005-2006 (%); Figure 14: UK Indigestion Preparations value & value forecast, 2001-2011 (GBP m, nominal prices); Figure 15: UK Indigestion Preparations category growth comparison, by value, 2001-2011; Figure 16: UK Indigestion Preparations company share, by value, 2005-2006 (%); Figure 17: UK Vitamins and Minerals value & value forecast, 2001-2011 (GBP m, nominal prices); Figure 18: UK Vitamins and Minerals category growth comparison, by value, 2001-2011; Figure 19: UK Vitamins and Minerals company share, by value, 2005-2006 (%); Figure 20: UK Plasters & Bandages value & value forecast, 2001-2011 (GBP m, nominal prices); Figure 21: UK Plasters & Bandages category growth comparison, by value, 2001-2011; Figure 22: UK Plasters & Bandages company share, by value, 2005-2006 (%); Figure 23: UK Medicated Skin Products value & value forecast, 2001-2011 (GBP m, nominal prices); Figure 24: UK Medicated Skin Products category growth comparison, by value, 2001-2011; Figure 25: UK Medicated Skin Products company share, by value, 2005-2006 (%); Figure 26: UK Other OTC Healthcare Products value & value forecast, 2001-2011 (GBP m, nominal prices); Figure 27: UK Other OTC Healthcare Products category growth comparison, by value, 2001-2011; Figure 28: UK Other OTC Healthcare Products company share, by value, 2005-2006 (%); Figure 29: UK Topical OTC Medicines value & value forecast, 2001-2011 (GBP m, nominal prices); Figure 30: UK Topical OTC Medicines category growth comparison, by value, 2001-2011; Figure 31: UK Topical OTC Medicines company share, by value, 2005-2006 (%); Figure 32: Global OTC Healthcare market split (value terms, 2006) - Top 5 countries; Figure 33: Global OTC Healthcare market value, 2001 - 2006 (Top 5 countries); Figure 34: Map of the UK; Figure 35: Annual data review process
LIST OF TABLES
: Table 1: OTC Healthcare category definitions; Table 2: UK OTC Healthcare value, 2001-2006 (GBP m, nominal prices); Table 3: UK OTC Healthcare value forecast, 2006-2011 (GBP m, nominal prices); Table 4: UK OTC Healthcare value, 2001-2006 (US$ m nominal prices); Table 5: UK OTC Healthcare value forecast, 2006-2011 (US$ m nominal prices); Table 6: UK OTC Healthcare brand share, by value, 2005-2006 (%); Table 7: UK OTC Healthcare value, by brand 2005-2006 (GBP m nominal prices); Table 8: UK OTC Healthcare company share by value, 2005-2006 (%); Table 9: UK OTC Healthcare value, by company, 2005-2006 (GBP m nominal prices); Table 10: UK OTC Healthcare expenditure per capita, 2001-2006 (GBP, nominal prices); Table 11: UK OTC Healthcare forecast expenditure per capita, 2006-2011 (GBP, nominal prices); Table 12: UK OTC Healthcare expenditure per capita, 2001-2006 (US$ nominal prices); Table 13: UK OTC Healthcare forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 14: GlaxoSmithKline Plc Key Facts; Table 15: Pfizer Inc Key Facts; Table 16: UK Analgesics value, 2001-2006 (GBP m, nominal prices); Table 17: UK Analgesics value forecast, 2006-2011 (GBP m, nominal prices); Table 18: UK Analgesics value, 2001-2006 (US$ m nominal prices); Table 19: UK Analgesics value forecast, 2006-2011 (US$ m nominal prices); Table 20: UK Analgesics brand share, by value, 2005-2006 (%); Table 21: UK Analgesics value, by brand 2005-2006 (GBP m nominal prices); Table 22: UK Analgesics company share by value, 2005-2006 (%); Table 23: UK Analgesics value, by company, 2005-2006 (GBP m nominal prices); Table 24: UK Analgesics expenditure per capita, 2001-2006 (GBP, nominal prices); Table 25: UK Analgesics forecast expenditure per capita, 2006-2011 (GBP, nominal prices); Table 26: UK Analgesics expenditure per capita, 2001-2006 (US$ nominal prices); Table 27: UK Analgesics forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 28: UK Cough and Cold Preparations value, 2001-2006 (GBP m, nominal prices); Table 29: UK Cough and Cold Preparations value forecast, 2006-2011 (GBP m, nominal prices); Table 30: UK Cough and Cold Preparations value, 2001-2006 (US$ m nominal prices); Table 31: UK Cough and Cold Preparations value forecast, 2006-2011 (US$ m nominal prices); Table 32: UK Cough and Cold Preparations brand share, by value, 2005-2006 (%); Table 33: UK Cough and Cold Preparations value, by brand 2005-2006 (GBP m nominal prices); Table 34: UK Cough and Cold Preparations company share by value, 2005-2006 (%); Table 35: UK Cough and Cold Preparations value, by company, 2005-2006 (GBP m nominal prices); Table 36: UK Cough and Cold Preparations expenditure per capita, 2001-2006 (GBP, nominal prices); Table 37: UK Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (GBP, nominal prices); Table 38: UK Cough and Cold Preparations expenditure per capita, 2001-2006 (US$ nominal prices); Table 39: UK Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 40: UK Traditional Medicines value, 2001-2006 (GBP m, nominal prices); Table 41: UK Traditional Medicines value forecast, 2006-2011 (GBP m, nominal prices); Table 42: UK Traditional Medicines value, 2001-2006 (US$ m nominal prices); Table 43: UK Traditional Medicines value forecast, 2006-2011 (US$ m nominal prices); Table 44: UK Traditional Medicines brand share, by value, 2005-2006 (%); Table 45: UK Traditional Medicines value, by brand 2005-2006 (GBP m nominal prices); Table 46: UK Traditional Medicines company share by value, 2005-2006 (%); Table 47: UK Traditional Medicines value, by company, 2005-2006 (GBP m nominal prices); Table 48: UK Traditional Medicines expenditure per capita, 2001-2006 (GBP, nominal prices); Table 49: UK Traditional Medicines forecast expenditure per capita, 2006-2011 (GBP, nominal prices); Table 50: UK Traditional Medicines expenditure per capita, 2001-2006 (US$ nominal prices); Table 51: UK Traditional Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 52: UK First Aid Kits value, 2001-2006 (GBP m, nominal prices); Table 53: UK First Aid Kits value forecast, 2006-2011 (GBP m, nominal prices); Table 54: UK First Aid Kits value, 2001-2006 (US$ m nominal prices); Table 55: UK First Aid Kits value forecast, 2006-2011 (US$ m nominal prices); Table 56: UK First Aid Kits brand share, by value, 2005-2006 (%); Table 57: UK First Aid Kits value, by brand 2005-2006 (GBP m nominal prices); Table 58: UK First Aid Kits company share by value, 2005-2006 (%); Table 59: UK First Aid Kits value, by company, 2005-2006 (GBP m nominal prices); Table 60: UK First Aid Kits expenditure per capita, 2001-2006 (GBP, nominal prices); Table 61: UK First Aid Kits forecast expenditure per capita, 2006-2011 (GBP, nominal prices); Table 62: UK First Aid Kits expenditure per capita, 2001-2006 (US$ nominal prices); Table 63: UK First Aid Kits forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 64: UK Indigestion Preparations value, 2001-2006 (GBP m, nominal prices); Table 65: UK Indigestion Preparations value forecast, 2006-2011 (GBP m, nominal prices); Table 66: UK Indigestion Preparations value, 2001-2006 (US$ m nominal prices); Table 67: UK Indigestion Preparations value forecast, 2006-2011 (US$ m nominal prices); Table 68: UK Indigestion Preparations brand share, by value, 2005-2006 (%); Table 69: UK Indigestion Preparations value, by brand 2005-2006 (GBP m nominal prices); Table 70: UK Indigestion Preparations company share by value, 2005-2006 (%); Table 71: UK Indigestion Preparations value, by company, 2005-2006 (GBP m nominal prices); Table 72: UK Indigestion Preparations expenditure per capita, 2001-2006 (GBP, nominal prices); Table 73: UK Indigestion Preparations forecast expenditure per capita, 2006-2011 (GBP, nominal prices); Table 74: UK Indigestion Preparations expenditure per capita, 2001-2006 (US$ nominal prices); Table 75: UK Indigestion Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 76: UK Vitamins and Minerals value, 2001-2006 (GBP m, nominal prices); Table 77: UK Vitamins and Minerals value forecast, 2006-2011 (GBP m, nominal prices); Table 78: UK Vitamins and Minerals value, 2001-2006 (US$ m nominal prices); Table 79: UK Vitamins and Minerals value forecast, 2006-2011 (US$ m nominal prices); Table 80: UK Vitamins and Minerals brand share, by value, 2005-2006 (%); Table 81: UK Vitamins and Minerals value, by brand 2005-2006 (GBP m nominal prices); Table 82: UK Vitamins and Minerals company share by value, 2005-2006 (%); Table 83: UK Vitamins and Minerals value, by company, 2005-2006 (GBP m nominal prices); Table 84: UK Vitamins and Minerals expenditure per capita, 2001-2006 (GBP, nominal prices); Table 85: UK Vitamins and Minerals forecast expenditure per capita, 2006-2011 (GBP, nominal prices); Table 86: UK Vitamins and Minerals expenditure per capita, 2001-2006 (US$ nominal prices); Table 87: UK Vitamins and Minerals forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 88: UK Plasters & Bandages value, 2001-2006 (GBP m, nominal prices); Table 89: UK Plasters & Bandages value forecast, 2006-2011 (GBP m, nominal prices); Table 90: UK Plasters & Bandages value, 2001-2006 (US$ m nominal prices); Table 91: UK Plasters & Bandages value forecast, 2006-2011 (US$ m nominal prices); Table 92: UK Plasters & Bandages brand share, by value, 2005-2006 (%); Table 93: UK Plasters & Bandages value, by brand 2005-2006 (GBP m nominal prices); Table 94: UK Plasters & Bandages company share by value, 2005-2006 (%); Table 95: UK Plasters & Bandages value, by company, 2005-2006 (GBP m nominal prices); Table 96: UK Plasters & Bandages expenditure per capita, 2001-2006 (GBP, nominal prices); Table 97: UK Plasters & Bandages forecast expenditure per capita, 2006-2011 (GBP, nominal prices); Table 98: UK Plasters & Bandages expenditure per capita, 2001-2006 (US$ nominal prices); Table 99: UK Plasters & Bandages forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 100: UK Medicated Skin Products value, 2001-2006 (GBP m, nominal prices); Table 101: UK Medicated Skin Products value forecast, 2006-2011 (GBP m, nominal prices); Table 102: UK Medicated Skin Products value, 2001-2006 (US$ m nominal prices); Table 103: UK Medicated Skin Products value forecast, 2006-2011 (US$ m nominal prices); Table 104: UK Medicated Skin Products brand share, by value, 2005-2006 (%); Table 105: UK Medicated Skin Products value, by brand 2005-2006 (GBP m nominal prices); Table 106: UK Medicated Skin Products company share by value, 2005-2006 (%); Table 107: UK Medicated Skin Products value, by company, 2005-2006 (GBP m nominal prices); Table 108: UK Medicated Skin Products expenditure per capita, 2001-2006 (GBP, nominal prices); Table 109: UK Medicated Skin Products forecast expenditure per capita, 2006-2011 (GBP, nominal prices); Table 110: UK Medicated Skin Products expenditure per capita, 2001-2006 (US$ nominal prices); Table 111: UK Medicated Skin Products forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 112: UK Other OTC Healthcare Products value, 2001-2006 (GBP m, nominal prices); Table 113: UK Other OTC Healthcare Products value forecast, 2006-2011 (GBP m, nominal prices); Table 114: UK Other OTC Healthcare Products value, 2001-2006 (US$ m nominal prices); Table 115: UK Other OTC Healthcare Products value forecast, 2006-2011 (US$ m nominal prices); Table 116: UK Other OTC Healthcare Products brand share, by value, 2005-2006 (%); Table 117: UK Other OTC Healthcare Products value, by brand 2005-2006 (GBP m nominal prices); Table 118: UK Other OTC Healthcare Products company share by value, 2005-2006 (%); Table 119: UK Other OTC Healthcare Products value, by company, 2005-2006 (GBP m nominal prices); Table 120: UK Other OTC Healthcare Products expenditure per capita, 2001-2006 (GBP, nominal prices); Table 121: UK Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (GBP, nominal prices); Table 122: UK Other OTC Healthcare Products expenditure per capita, 2001-2006 (US$ nominal prices); Table 123: UK Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 124: UK Topical OTC Medicines value, 2001-2006 (GBP m, nominal prices); Table 125: UK Topical OTC Medicines value forecast, 2006-2011 (GBP m, nominal prices); Table 126: UK Topical OTC Medicines value, 2001-2006 (US$ m nominal prices); Table 127: UK Topical OTC Medicines value forecast, 2006-2011 (US$ m nominal prices); Table 128: UK Topical OTC Medicines brand share, by value, 2005-2006 (%); Table 129: UK Topical OTC Medicines value, by brand 2005-2006 (GBP m nominal prices); Table 130: UK Topical OTC Medicines company share by value, 2005-2006 (%); Table 131: UK Topical OTC Medicines value, by company, 2005-2006 (GBP m nominal prices); Table 132: UK Topical OTC Medicines expenditure per capita, 2001-2006 (GBP, nominal prices); Table 133: UK Topical OTC Medicines forecast expenditure per capita, 2006-2011 (GBP, nominal prices); Table 134: UK Topical OTC Medicines expenditure per capita, 2001-2006 (US$ nominal prices); Table 135: UK Topical OTC Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 136: Global OTC Healthcare market value, 2006; Table 137: Global OTC Healthcare market split (value terms (US$ m), 2006) - Top 5 countries; Table 138: Leading players - Top 5 countries; Table 139: UK OTC Healthcare new product launches (reports) and SKUs, by company (Top 5 companies), 2006; Table 140: UK OTC Healthcare new product launches (reports), by flavor and fragrances (Top 10 flavors), 2006; Table 141: UK OTC Healthcare new product launches (reports), by Ingredients (Top 10 Ingredients), 2006; Table 142: UK OTC Healthcare new product launches (reports), by Package tags or Claims (Top 10 claims), 2006; Table 143: UK OTC Healthcare new product launches (reports) - Recent 5 launches; Table 144: UK Key Facts; Table 145: UK population, by age group, 2000-2005 (millions); Table 146: UK population forecast, by age group, 2005-2010 (millions); Table 147: UK population, by gender, 2000-2005 (millions); Table 148: UK population forecast, by gender, 2005-2010 (millions); Table 149: UK real GDP, 2000-2005 (GBP bn, 2005 prices); Table 150: UK real GDP forecast, 2005-2010 (GBP bn, 2005 prices); Table 151: UK nominal GDP, 2000-2005 (GBP bn, nominal prices); Table 152: UK real GDP, 2000-2005 (US$ bn, 2005 prices); Table 153: UK real GDP forecast, 2005-2010 (US$ bn, 2005 prices); Table 154: UK consumer price index, 2000-2005 (2000=100); Table 155: UK consumer price index, 2005-2010 (2000=100); Table 156: UK exchange rate, 2000-2005

More United Kingdom Over-the-Counter Drugs Reports

OTC Pharmaceuticals in the United Kingdom by MarketLine
Introduction OTC Pharmaceuticals in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2006-10, and ...

A Comprehensive Study Of The UK Healthcare Preparations Market In 2010, Rating & Valuing Each Of The 67 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

A Comprehensive Study Of The UK Aromatherapy Products Market In 2010, Rating & Valuing Each Of The 110 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

OTC Pharmaceuticals – UK – a snapshot (2011) by Mintel - Snapshots
OTC Pharmaceuticals in UK by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers ...

OTC Triptans in the United Kingdom by Euromonitor International
In 2010 sales of OTC triptans were worth approaching £5 million, up 35% in current terms on 2009. Migraines already affect 15% of adults in ...

See all reports like this >>

More United Kingdom Reports

A Comprehensive Study Of The UK Video Conferencing Equipment Market In 2010, Rating & Valuing Each Of The 30 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

A Comprehensive Study Of The UK Tableware Market In 2010, Rating & Valuing Each Of The 166 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

A Comprehensive Study Of The UK Surveyors & Valuers Market In 2010, Rating & Valuing Each Of The 943 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

A Comprehensive Study Of The UK Subsea Engineering Market In 2010, Rating & Valuing Each Of The 142 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

A Comprehensive Study Of The UK Structural Engineering Consultancy Market In 2010, Rating & Valuing Each Of The 300 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

See all reports like this >>

OTC Healthcare in the UK to 2011

Share this report

Other tasks

Research Assistance

Related Markets

Over-the-Counter Drugs Reports

Free Alert Me service